TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Sysmex ( (JP:6869) ).
Sysmex Corporation announced its decision to absorb its wholly owned subsidiary, Sysmex Medica Co., Ltd., to streamline its equipment production process and enhance efficiency. The merger, set to be effective from April 1, 2026, will be conducted as an absorption-type merger, with Sysmex Corporation as the surviving entity, and is expected to improve productivity without the issuance of new shares or monetary allotments.
The most recent analyst rating on (JP:6869) stock is a Buy with a Yen2400.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation operates in the healthcare industry, focusing on the development, manufacture, sales, and export/import of diagnostic instruments, reagents, and related software. The company is known for its comprehensive solutions in diagnostics and aims to optimize production processes within its group companies.
Average Trading Volume: 3,057,703
Technical Sentiment Signal: Sell
Current Market Cap: Yen936.7B
Learn more about 6869 stock on TipRanks’ Stock Analysis page.